Riskpilot← Back to searchSign inGet full accessHarken&Co Holding ApS
APSActiveCVR 36707631Nydamsvej 13Activities of holding companies · NACE 6421Est. 2015— employees
Revenue 2025
DKK -2K
+80% vs 2024
EBITDA margin
100.0%
-80% vs 2024
Equity ratio
78.6%
Financial strength
Net profit 2025
DKK -534K
-16% vs 2024
| Revenue | DKK -2K | +80% |
| EBITDA | DKK -2K | -80% |
| Net profit | DKK -534K | -16% |
| Total assets | DKK 3,6M | -12% |
| Equity | DKK 2,8M | -22% |
| Employees | — | — |
Legal name
Harken&Co Holding ApS
CVR number
36707631
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
1. april 2015
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af den samlede bestyrelse eller
af en direktør alene.
Company purpose
Selskabets formål er at besidde fast ejendom og kapitalandele i aktie- og/eller anpartsselskaber eller hermed beslægtet virksomhed.
Address
Nydamsvej 13
Phone
+4586923333
Email
ch@natur-drogeriet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -2 | -1 | -1 | -1 | -2 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -2 | -1 | -1 | -1 | -2 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -2 | -1 | -1 | -1 | -2 |
| Net financials | 1.037 | -1.128 | 1.306 | -458 | -531 |
| Profit before tax | 1.035 | -1.130 | 1.304 | -459 | -534 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 1.035 | -1.130 | 1.304 | -459 | -534 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5.178 | 3.508 | 4.727 | 4.114 | 3.609 |
| Equity | 4.455 | 2.925 | 4.230 | 3.620 | 2.837 |
| Long-term debt | 553 | 412 | 266 | 19 | 0 |
| Short-term debt | 170 | 171 | 172 | 216 | 83 |
| Total debt | 724 | 583 | 438 | 234 | 83 |
EBITDA margin
-225100.0%
This company
15.8%
Market median
-1424784% vs market
20212025
Equity ratio
78.6%
This company
38.2%
Market median
+106% vs market
20212025
Return on equity
-18.8%
This company
18.4%
Market median
-202% vs market
20212025
Net profit margin
-53357700.0%
This company
8.1%
Market median
-658737137% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Founder | Founder | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Harken&Co Holding ApS (this company)
NATUR-DROGERIET A/SBoard members of Harken&Co Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikkel Salling | Founder | 0 companies |
| Jonna Harken Christiansen | Board of Directors | 0 companies |